Cargando…

1217. Clinical and Microbiological Characteristics of Patients with Bacteremia and Normal Procalcitonin at Single Tertiary Care Medical Center

BACKGROUND: Procalcitonin (PCT) is a serum biomarker used to diagnose bacterial infections and guide antibiotic therapy. Many studies highlight its high sensitivity, specificity, and negative predictive value for bacteremia. PCT > 2ng/mL has been reported to be strongly indicative of systemic bac...

Descripción completa

Detalles Bibliográficos
Autores principales: Boussi, Leora, Popli, Tarun, Feola, Nicholas, Nog, Rajat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777248/
http://dx.doi.org/10.1093/ofid/ofaa439.1402
_version_ 1783630858467409920
author Boussi, Leora
Popli, Tarun
Feola, Nicholas
Nog, Rajat
author_facet Boussi, Leora
Popli, Tarun
Feola, Nicholas
Nog, Rajat
author_sort Boussi, Leora
collection PubMed
description BACKGROUND: Procalcitonin (PCT) is a serum biomarker used to diagnose bacterial infections and guide antibiotic therapy. Many studies highlight its high sensitivity, specificity, and negative predictive value for bacteremia. PCT > 2ng/mL has been reported to be strongly indicative of systemic bacterial infection, with values of .5-2ng/mL suggesting localized infection and < .5ng/mL strongly suggesting absence of infection. However, emerging reports have raised concerns about PCT in bacteremia, demonstrating low sensitivity. Few studies have characterized patients with bacteremia and low PCT. We aimed to analyze the clinical and microbiological characteristics of patients with bacteremia and PCT < 2ng/mL. METHODS: Adult patients admitted at Westchester Medical Center with bacteremia and associated PCT level within 24 hours (hrs) prior to 48 hrs post blood culture collection from 1/1/2014-9/30/2019 were included. Demographic, clinical, laboratory, and microbiological data were retrospectively collected and analyzed. RESULTS: There were 414 total cases of bacteremia with an associated PCT level within 24 hrs prior to 48 hrs post blood culture collection. 209 of 414 (50.5%) patients had PCT < 2ng/mL. Of these, 86 were excluded (73 contaminants, defined as bacteremia not causing systemic inflammation and not treated, 10 fungal cultures, and 3 lacking data). Of the remaining 123 (37.5%) patients with PCT < 2ng/mL, 66 (53.7%) had PCT<. 5ng/mL. The leading infection source was endovascular/line-related at 31.7%, followed by intraabdominal/gastrointestinal and urinary. 30.9% of bloodstream organisms were gram negative. Among these 123 patients with PCT < 2ng/mL, in-hospital mortality with bacteremia clinically contributing to death was 13%. Characteristics of patients with bacteremia and procalcitonin < 2ng/mL [Image: see text] CONCLUSION: Despite literature supporting the use of PCT algorithms in initiation and de-escalation of antibiotics in patients with suspected bacterial infections, a substantial percentage of bacteremic patients can have low PCT but significant infection-related mortality. Therefore, PCT should not be the only factor utilized by clinicians in the management of such patients, including initiating or deescalating antibiotics. Further studies are needed to characterize patient characteristics as contributing factors for bacteremia with low PCT. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-7777248
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77772482021-01-07 1217. Clinical and Microbiological Characteristics of Patients with Bacteremia and Normal Procalcitonin at Single Tertiary Care Medical Center Boussi, Leora Popli, Tarun Feola, Nicholas Nog, Rajat Open Forum Infect Dis Poster Abstracts BACKGROUND: Procalcitonin (PCT) is a serum biomarker used to diagnose bacterial infections and guide antibiotic therapy. Many studies highlight its high sensitivity, specificity, and negative predictive value for bacteremia. PCT > 2ng/mL has been reported to be strongly indicative of systemic bacterial infection, with values of .5-2ng/mL suggesting localized infection and < .5ng/mL strongly suggesting absence of infection. However, emerging reports have raised concerns about PCT in bacteremia, demonstrating low sensitivity. Few studies have characterized patients with bacteremia and low PCT. We aimed to analyze the clinical and microbiological characteristics of patients with bacteremia and PCT < 2ng/mL. METHODS: Adult patients admitted at Westchester Medical Center with bacteremia and associated PCT level within 24 hours (hrs) prior to 48 hrs post blood culture collection from 1/1/2014-9/30/2019 were included. Demographic, clinical, laboratory, and microbiological data were retrospectively collected and analyzed. RESULTS: There were 414 total cases of bacteremia with an associated PCT level within 24 hrs prior to 48 hrs post blood culture collection. 209 of 414 (50.5%) patients had PCT < 2ng/mL. Of these, 86 were excluded (73 contaminants, defined as bacteremia not causing systemic inflammation and not treated, 10 fungal cultures, and 3 lacking data). Of the remaining 123 (37.5%) patients with PCT < 2ng/mL, 66 (53.7%) had PCT<. 5ng/mL. The leading infection source was endovascular/line-related at 31.7%, followed by intraabdominal/gastrointestinal and urinary. 30.9% of bloodstream organisms were gram negative. Among these 123 patients with PCT < 2ng/mL, in-hospital mortality with bacteremia clinically contributing to death was 13%. Characteristics of patients with bacteremia and procalcitonin < 2ng/mL [Image: see text] CONCLUSION: Despite literature supporting the use of PCT algorithms in initiation and de-escalation of antibiotics in patients with suspected bacterial infections, a substantial percentage of bacteremic patients can have low PCT but significant infection-related mortality. Therefore, PCT should not be the only factor utilized by clinicians in the management of such patients, including initiating or deescalating antibiotics. Further studies are needed to characterize patient characteristics as contributing factors for bacteremia with low PCT. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2020-12-31 /pmc/articles/PMC7777248/ http://dx.doi.org/10.1093/ofid/ofaa439.1402 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Abstracts
Boussi, Leora
Popli, Tarun
Feola, Nicholas
Nog, Rajat
1217. Clinical and Microbiological Characteristics of Patients with Bacteremia and Normal Procalcitonin at Single Tertiary Care Medical Center
title 1217. Clinical and Microbiological Characteristics of Patients with Bacteremia and Normal Procalcitonin at Single Tertiary Care Medical Center
title_full 1217. Clinical and Microbiological Characteristics of Patients with Bacteremia and Normal Procalcitonin at Single Tertiary Care Medical Center
title_fullStr 1217. Clinical and Microbiological Characteristics of Patients with Bacteremia and Normal Procalcitonin at Single Tertiary Care Medical Center
title_full_unstemmed 1217. Clinical and Microbiological Characteristics of Patients with Bacteremia and Normal Procalcitonin at Single Tertiary Care Medical Center
title_short 1217. Clinical and Microbiological Characteristics of Patients with Bacteremia and Normal Procalcitonin at Single Tertiary Care Medical Center
title_sort 1217. clinical and microbiological characteristics of patients with bacteremia and normal procalcitonin at single tertiary care medical center
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777248/
http://dx.doi.org/10.1093/ofid/ofaa439.1402
work_keys_str_mv AT boussileora 1217clinicalandmicrobiologicalcharacteristicsofpatientswithbacteremiaandnormalprocalcitoninatsingletertiarycaremedicalcenter
AT poplitarun 1217clinicalandmicrobiologicalcharacteristicsofpatientswithbacteremiaandnormalprocalcitoninatsingletertiarycaremedicalcenter
AT feolanicholas 1217clinicalandmicrobiologicalcharacteristicsofpatientswithbacteremiaandnormalprocalcitoninatsingletertiarycaremedicalcenter
AT nograjat 1217clinicalandmicrobiologicalcharacteristicsofpatientswithbacteremiaandnormalprocalcitoninatsingletertiarycaremedicalcenter